Ralph A. Rivero

2.2k citations

62 papers · 1.5k indexed · h-index 22

Impact in

Organic Chemistry top 2%
- Carbohydrate Chemistry and Synthesis
- Catalytic C–H Functionalization Methods
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
Molecular Biology top 10%
- Chemical Synthesis and Analysis
- Receptor Mechanisms and Signaling

Papers in

Organic Chemistry 27
- Click Chemistry and Applications 6
- Quinazolinone synthesis and applications 5
- Synthesis and Catalytic Reactions 4
Pharmacology 6

Co-authors: Jung Lee Amos B. Smith Jay M. Matthews Alexey B. Dyatkin George Burton Karl J. Hale William J. Greenlee Henry A. Vaccaro
Journals: Bioorganic & Medicinal Chemistry Letters (25 papers)Tetrahedron Letters (9 papers)Journal of the American Chemical Society (5 papers)The Journal of Organic Chemistry (5 papers)ACS Medicinal Chemistry Letters (3 papers)
Partner nations: United States United Kingdom Denmark

In The Last Decade

Ralph A. Rivero

62 papers receiving 1.4k citations

Peers

Countries citing papers authored by Ralph A. Rivero

Since Specialization

Citations

This map shows the geographic impact of Ralph A. Rivero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph A. Rivero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph A. Rivero more than expected).

Fields of papers citing papers by Ralph A. Rivero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph A. Rivero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph A. Rivero. The network helps show where Ralph A. Rivero may publish in the future.

Co-authors

The 25 scholars most cited alongside Ralph A. Rivero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ralph A. Rivero Line = papers co-authored together Ralph A. Rivero links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Design and synthesis of aminopyridine containing biaryls reducing c-MYC protein levels in cells Bioorganic & Medicinal Chemistry Letters ·Christina N. Di Marco, Lamont R. Terrell, Robert A. Sanchez, Lourdes Rueda, 良助高木, Bibi Sedighe Fazli Bazzaz, Charles F. McHugh, Yo-Wan Kim, Arthur Y. L. Shu, Xinrong Tian, Jesús R. Medina, Ralph A. Rivero, Roman Manetsch, Dirk A. Heerding, J. Yuge	2023	1
2	Identification, Synthesis, and Characterization of a Major Circulating Human Metabolite of TRPV4 Antagonist GSK2798745 ACS Medicinal Chemistry Letters ·稲田弘二, K. V Smirnov, David J. Behm, Jacques Briand, Sabine Philipp, Karl F. Erhard, Andrew D. Roberts, Ralph A. Rivero, Dennis A. Holt, Brian G. Lawhorn	2021	12
3	Synthesis and structure–activity relationships of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones as novel series of potent β isoform selective phosphatidylinositol 3-kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·María-Celina Penchansky, Karl F. Erhard, Mary Ann Hardwicke, Hong Lin, Jeanelle McSurdy-Freed, Ramona Plant, Kaushik Raha, Cynthia M. Rominger, Michael D. Schaber, Michael D. Spengler, Michael L. Moore, Hongyi Yu, Juan I. Luengo, Rosanna Tedesco, Ralph A. Rivero	2012	42
4	Synthesis and structure–activity relationships of imidazo[1,2-a]pyrimidin-5(1H)-ones as a novel series of beta isoform selective phosphatidylinositol 3-kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Hong Lin, Karl F. Erhard, Mary Ann Hardwicke, Juan I. Luengo, Yo-Wan Kim, Jeanelle McSurdy-Freed, Ramona Plant, Kaushik Raha, Cynthia M. Rominger, María-Celina Penchansky, Michael D. Schaber, Mark J. Schulz, Michael D. Spengler, Rosanna Tedesco, Nicholas Wedige, Jin Zeng, Ralph A. Rivero	2012	31
5	Abstract 2913: Identification of GSK2636771, a potent and selective, orally bioavailable inhibitor of phosphatidylinositol 3-kinase-beta (PI3Kα) for the treatment of PTEN deficient tumors Cancer Research ·Ralph A. Rivero, Mary Ann Hardwicke	2012	7
6	Synthesis and structure–activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists Bioorganic & Medicinal Chemistry Letters ·C Parer, Karen A. Evans, David D. Wisnoski, Jian Jin, Ralph A. Rivero, Ellen Johnston, Channa Jayawickreme, Levin Ai, Hongshi Yu	2010	39
7	M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines Bioorganic & Medicinal Chemistry Letters ·C Parer, Yonghui Wang, 余佳泓, Feng Wang, Haibo Xie, Zehong Wan, Megan van der Bank, James J. Foley, Parvathi Nuthulaganti, Lorena A. Kallal, Henry M. Sarau, Dwight M. Morrow, M. Lane Moore, Ralph A. Rivero, Michael R. Palovich, M Salmon, Kristen E. Belmonte, Dramane I. Lainé, Jian Jin	2009	4
8	N-Alkyl-5H-pyrido[4,3-b]indol-1-amines and derivatives as novel urotensin-II receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Yonghui Wang, Zining Wu, B.O. Ríos Velázquez, Gonzalo Yamauchi, Michael J. Neeb, Ralph A. Rivero, Stephen A. Douglas, Jian Jin	2008	15
9	Urotensin-II receptor antagonists: Synthesis and SAR of N-cyclic azaalkyl benzamides Bioorganic & Medicinal Chemistry Letters ·Jian Jin, Ming An, Anthony Sapienza, Nambi Aiyar, Diane P. Naselsky, Henry M. Sarau, James J. Foley, Kevin L. Salyers, Steven D. Knight, Richard M. Keenan, Ralph A. Rivero, Dashyant Dhanak, Stephen A. Douglas	2008	14
10	Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas Bioorganic & Medicinal Chemistry Letters ·Jian Jin, Yonghui Wang, 余佳泓, Feng Wang, Wei Fu, 谷川俊貴, Qi Jin, James J. Foley, Henry M. Sarau, Dwight M. Morrow, Michael L. Moore, Ralph A. Rivero, Michael R. Palovich, M Salmon, Kristen E. Belmonte, Jakob Busch‐Petersen	2008	2
11	2-Aminomethyl piperidines as novel urotensin-II receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Jian Jin, Yonghui Wang, Feng Wang, 余佳泓, Karl F. Erhard, Zining Wu, B.O. Ríos Velázquez, Gonzalo Yamauchi, David J. Behm, Jyoti Disa, Kalindi Vaidya, Christopher A. Evans, Luiz Guilherme Oliveira, Ralph A. Rivero, Michael J. Neeb, Stephen A. Douglas	2008	11
12	Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists Bioorganic & Medicinal Chemistry Letters ·Yonghui Wang, Jakob Busch‐Petersen, Feng Wang, D. G. Melo, Todd L. Graybill, Jian Jin, Zheng Yang, James J. Foley, Zapata Caicedo, Dulcie B. Schmidt, Henry M. Sarau, Shentong Yu, Zining Wu, Rejane Dias da Silva Caires, Michael S. McQueney, Ralph A. Rivero, Katherine L. Widdowson	2008	33
13	Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Sigmond G. Johnson, Joseph W. Gunnet, John B. Moore, Kolar Sridara Murthy Meena, Pam Wines, Ralph A. Rivero, F Likis, Keith T. Demarest	2006	5
14	An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: Potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase Bioorganic & Medicinal Chemistry Letters ·Karen A. Evans, Deping Chai, Todd L. Graybill, George Burton, Robert T. Sarisky, Juili Lin-Goerke, Victor K. Johnston, Ralph A. Rivero	2006	28
15	2,3-Diaryl-5-anilino[1,2,4]thiadiazoles as melanocortin MC4 receptor agonists and their effects on feeding behavior in rats Bioorganic & Medicinal Chemistry ·Yong Yi Cui, Malcolm K. Scott, Daniel H. S. Lee, Daniel Bush, G. Harishmitha, Ralph A. Rivero, Daniel I. Rosenthal, Anil H. Vaidya, Boyu Zhao, Allen B. Reitz	2003	42
16	Synthesis and structure–activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor Bioorganic & Medicinal Chemistry Letters ·Jung Lee, T. Fujiwara, Ralph A. Rivero, Allen B. Reitz, Richard P. Shank	2000	13
17	A Visual Tagging Process for Mix and Sort Combinatorial Chemistry Angewandte Chemie International Edition ·Joseph W. Guiles, 何梅, Ralph A. Rivero	1998	20
18	Non-peptide Angiotensin Agonist Journal of Biological Chemistry ·Julio Oliveira, Hans Schambye, Ralph A. Rivero, William J. Greenlee, Siv A. Hjorth, Thue W. Schwartz	1995	84
19	Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor Chemistry & Biology ·Dennis Underwood, Catherine D. Strader, Ralph A. Rivero, Arthur A. Patchett, William J. Greenlee, Kristine Prendergast	1994	55
20	The synthesis of novel macrocyclic inhibitors of human renin Tetrahedron Letters ·Ralph A. Rivero, W. J. GREENLEE	1991	13

About Ralph A. Rivero

Ralph A. Rivero is a scholar working on Organic Chemistry, Pharmacology, Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology, having authored 62 papers that have together received 1.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (17 papers), Chemical Synthesis and Analysis (14 papers), Neuropeptides and Animal Physiology (7 papers), Click Chemistry and Applications (6 papers), Renin-Angiotensin System Studies (6 papers), Quinazolinone synthesis and applications (5 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers) and Synthesis and Catalytic Reactions (4 papers). The work is most often cited by research in Organic Chemistry (852 citations), Molecular Biology (852 citations), Cellular and Molecular Neuroscience (190 citations), Pharmacology (115 citations) and Cardiology and Cardiovascular Medicine (141 citations). Ralph A. Rivero has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Jung Lee, Amos B. Smith, Jay M. Matthews, Alexey B. Dyatkin, George Burton, Karl J. Hale, William J. Greenlee, Henry A. Vaccaro, Ping Cao and Gang Li. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Journal of the American Chemical Society, The Journal of Organic Chemistry and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact